NCT02400892

Brief Summary

This study will involve patients who are planned to have hip or knee replacement surgeries. They will undergo a Transthoracic Echocardiogram study (an ultrasound of the heart) to look for a Patent Foramen Ovale (PFO). A PFO is a hole in the heart that everyone is born with and in most cases eventually closes by adulthood. However, it does not always close in all people. The investigators will compare the participants as two groups - those with a PFO, and those without, and look for differences in delirium in their postoperative stay. This will help us look for an association between postoperative delirium and the presence of a PFO.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
226

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

March 24, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 27, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

September 7, 2016

Status Verified

September 1, 2016

Enrollment Period

1.3 years

First QC Date

March 24, 2015

Last Update Submit

September 6, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative delirium - measured by Confusion Assessment Method (CAM) Scores positive for delirium

    Daily CAM assessment starting Postoperative Day #1 after surgery until discharge or up to 1 week postoperatively

Secondary Outcomes (2)

  • Length of hospital stay

    Postoperative length of hospital stay after surgery( expected mean of 4 days)

  • Major adverse events (including Heart Attack, Stroke, Heart failure, Blood clots, Abnormal heart rhythms, other major complications, and death)

    Postoperative period until hospital discharge (expected mean of 4 days)

Study Arms (2)

PFO

Subjects with a bedside Transthoracic Echocardiogram (TTE) bubble study positive for a PFO

Other: TTE Bubble Study

Control

Subjects with a bedside TTE bubble study negative for a PFO

Other: TTE Bubble Study

Interventions

Bedside transthoracic echocardiogram bubble study to assess for the presence or absence of a PFO

ControlPFO

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will involve adult patients planned to undergo an elective, primary hip or knee replacement surgery at one of the hospitals of the London Health Sciences Centre (University Hospital or Victoria Hospital).

You may qualify if:

  • Planned to undergo an elective, primary hip replacement surgery or knee replacement surgery
  • Fluent in English

You may not qualify if:

  • Planned to undergo a revision knee or hip replacement
  • History of cardiac surgery or prosthetic heart valves
  • History of other structural heart abnormalities, not involving the atrial septum
  • History of preexisting neurologic condition that affects the patient's day-to-day life, including a history of Dementia, Stroke, or previous Neurosurgery causing ongoing problems
  • Significant visual problems felt by investigators to impair Confusion Assessment Method use
  • Significant hearing problems felt by investigators to impair Confusion Assessment Method use
  • History of psychiatric problems requiring treatment with major antidepressant drugs or antipsychotic drugs
  • History of a Deep Venous Thrombosis or Pulmonary Embolism in the past year
  • History of known Atrial Fibrillation in the past 3 months
  • Presence of a pacemaker or implantable cardioverter-defibrillator
  • History of Transient Ischemic Attack or Stroke within the past year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

London, Ontario, N6G 2V4, Canada

Location

Related Publications (1)

  • Gai N, Lavi R, Jones PM, Lee H, Naudie D, Bainbridge D. The use of point-of-care ultrasound to diagnose patent foramen ovale in elective hip and knee arthroplasty patients and its association with postoperative delirium. Can J Anaesth. 2018 Jun;65(6):619-626. doi: 10.1007/s12630-018-1073-7. Epub 2018 Jan 24.

MeSH Terms

Conditions

Foramen Ovale, PatentDelirium

Condition Hierarchy (Ancestors)

Heart Septal Defects, AtrialHeart Septal DefectsHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Daniel Bainbridge, MD, FRCPC

    Western University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 24, 2015

First Posted

March 27, 2015

Study Start

March 1, 2015

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

September 7, 2016

Record last verified: 2016-09

Locations